CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 26 enrolled
Drug / intervention
Bitestripother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03833505
NCT03833505N/ACompleted

Evaluation of Relationship Between Enterobius Vermicularis Infection and Bruxism in Children

Aydin Adnan Menderes University·observational·Posted Feb 7, 2019·Updated Feb 7, 2019

In Brief

An observational study evaluating Bitestrip for Bruxism, Sleep. Completed, enrolled 26 participants across 1 site.

Detailed Summary

Background. Bruxism is an involuntary, non-functional activity of the masticatory system, and is frequently seen in childhood. Bruxism has many aetiologies, like malocclusion, psychological factors, allergies and gastrointestinal disorders. Aim. To investigate the relationship between Enterobius vermicularis infection and bruxism in children.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsBruxism, Sleep
CountriesTurkey (Türkiye)
Collaborators--

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedFeb 7, 2019
Enrollment StartMar 15, 2017
Primary CompletionMay 20, 2018
Study CompletionAug 15, 2018
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 7.4 years ago

Interventions

Bitestripother

The parents of the patients were asked to complete a survey that included questions about the demographic data, medical history of the patient, clinical findings of E. For diagnosis of sleep bruxism, a single-use BiteStrip® device (Up2dent, Inc.), including an electromyographic electrode, small display screen and lithium cell, was used to record the increased electromyographic activity of the masticatory muscles during sleep and bruxism, other harmful oral habits, family life and habits.